Dr. Lynne Postovit appointed Head, Department of Biomedical and Molecular Sciences
Faculty of Health Sciences Dean Richard Reznick is pleased to announce that Tom Harris, Interim Provost and Principal (Academic) at Queen’s University, has appointed Dr. Lynne-Marie Postovit as Head of the Department of Biomedical and Molecular Sciences. Her appointment will be for a five-year term beginning on October 1, 2019.
Dean Reznick would like to extend his sincere thanks to Dr. Thomas Massey for his service and leadership as Interim Head of the Department of Biomedical and Molecular Sciences.
Dr. Postovit earned her Bachelor of Science (Honours) at Queen’s University in 1999. After receiving her PhD in Anatomy and Cell Biology at Queen’s, Dr. Postovit completed a CIHR Postdoctoral Fellowship at Northwestern University in the Department of Cancer Biology and Epigenomics. Dr. Postovit was an Assistant Professor at Western University from 2007-2013 and has been an Associate Professor at the University of Alberta since 2014, where she co-directed the Cancer Research Institute of Northern Alberta.
As a recognized authority on ovarian cancer, Dr. Postovit has published more than 60 papers in peer-reviewed journals, including the International Journal of Molecular Science, Frontiers in Immunology, and Scientific Reports. Dr. Postovit has been invited to present her work at national and international research institutes and conferences, including the Karolinska Institute in Sweden and the Canadian Cancer Research Conference. In 2009, she was the recipient of the Peter Lougheed/CIHR New Investigator Award. Demonstrating excellence as a researcher, Dr. Postovit was elected as a Member of the Royal Society of Canada’s College of New Scholars, Artists, and Scientists in 2016.
In addition to her prolific research output, Dr. Postovit has made remarkable contributions to the wider community through her service to the profession. She serves on the editorial boards of Oncology Signaling, Scientific Reports, and the Journal of Cell Communication and Signaling. In 2018, Dr. Postovit chaired the Canadian Conference on Ovarian Cancer Research and was an organizing committee member for the Canadian Oxidative Stress Consortium. She has made outreach and public-facing research a priority as part of her career, participating in a number of community events such as Ovarian Cancer Canada Run for Hope and the Royal Alex Foundation.
Dr. Postovit has proven herself to be an effective, inspiring, and committed educator. Her exceptional mentorship is exemplified by the success of her undergraduate, graduate, and postdoctoral students who have published widely and hold numerous competitive scholarships.
Please join us in congratulating Dr. Postovit on her appointment as Head.